230 related articles for article (PubMed ID: 33154943)
1. Trimodal Therapy vs. Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Meta-Analysis.
Ding H; Fan N; Ning Z; Ma D
Front Oncol; 2020; 10():564779. PubMed ID: 33154943
[No Abstract] [Full Text] [Related]
2. Comparing trimodal therapy with radical cystectomy in muscle-invasive bladder cancer: an updated meta-analysis.
Al-Qudimat AR; Singh K; Ojha LK; Moustafa DA; Elaarag M; Al-Zoubi RM; Aboumarzouk OM
Front Surg; 2023; 10():1276746. PubMed ID: 38130884
[TBL] [Abstract][Full Text] [Related]
3. Oncological effectiveness of bladder-preserving trimodal therapy versus radical cystectomy for the treatment of muscle-invasive bladder cancer: a system review and meta-analysis.
Su X; Dong C; Liao W; Liu W
World J Surg Oncol; 2023 Aug; 21(1):271. PubMed ID: 37641150
[TBL] [Abstract][Full Text] [Related]
4. Comparative Effectiveness of Trimodal Therapy Versus Radical Cystectomy for Localized Muscle-invasive Urothelial Carcinoma of the Bladder.
Seisen T; Sun M; Lipsitz SR; Abdollah F; Leow JJ; Menon M; Preston MA; Harshman LC; Kibel AS; Nguyen PL; Bellmunt J; Choueiri TK; Trinh QD
Eur Urol; 2017 Oct; 72(4):483-487. PubMed ID: 28412065
[TBL] [Abstract][Full Text] [Related]
5. Outcomes for Muscle-invasive Bladder Cancer with Radical Cystectomy or Trimodal Therapy in US Veterans.
Kumar A; Cherry DR; Courtney PT; Nalawade V; Kotha N; Riviere PJ; Efstathiou J; McKay RR; Karim Kader A; Rose BS; Stewart TF
Eur Urol Open Sci; 2021 Aug; 30():1-10. PubMed ID: 34337540
[TBL] [Abstract][Full Text] [Related]
6. Bladder preservation approach versus radical cystectomy for high-grade non-muscle-invasive bladder cancer: a meta-analysis of cohort studies.
Shen PL; Lin ME; Hong YK; He XJ
World J Surg Oncol; 2018 Oct; 16(1):197. PubMed ID: 30285788
[TBL] [Abstract][Full Text] [Related]
7. Radical cystectomy versus organ-sparing trimodality treatment in muscle-invasive bladder cancer: A systematic review of clinical trials.
Arcangeli G; Strigari L; Arcangeli S
Crit Rev Oncol Hematol; 2015 Sep; 95(3):387-96. PubMed ID: 25934521
[TBL] [Abstract][Full Text] [Related]
8. Trimodal therapy vs radical cystectomy in patients with muscle-invasive bladder cancer: a systematic review and meta-analysis of comparative studies.
Ditonno F; Veccia A; Montanaro F; Pettenuzzo G; Franco A; Manfredi C; Triggiani L; De Nunzio C; De Sio M; Cerruto M; Crivellaro S; Kutikov A; Autorino R; Antonelli A
BJU Int; 2024 Apr; ():. PubMed ID: 38622957
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
Chen J; Zhang H; Sun G; Zhang X; Zhao J; Liu J; Shen P; Shi M; Zeng H
Int J Surg; 2018 Apr; 52():214-220. PubMed ID: 29496649
[TBL] [Abstract][Full Text] [Related]
10. A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Fahmy O; Khairul-Asri MG; Schubert T; Renninger M; Malek R; Kübler H; Stenzl A; Gakis G
Urol Oncol; 2018 Feb; 36(2):43-53. PubMed ID: 29102254
[TBL] [Abstract][Full Text] [Related]
11. Propensity Score Analysis of Radical Cystectomy Versus Bladder-Sparing Trimodal Therapy in the Setting of a Multidisciplinary Bladder Cancer Clinic.
Kulkarni GS; Hermanns T; Wei Y; Bhindi B; Satkunasivam R; Athanasopoulos P; Bostrom PJ; Kuk C; Li K; Templeton AJ; Sridhar SS; van der Kwast TH; Chung P; Bristow RG; Milosevic M; Warde P; Fleshner NE; Jewett MAS; Bashir S; Zlotta AR
J Clin Oncol; 2017 Jul; 35(20):2299-2305. PubMed ID: 28410011
[TBL] [Abstract][Full Text] [Related]
12. Muscle-invasive bladder cancer organ-preserving therapy: systematic review and meta-analysis.
García-Perdomo HA; Montes-Cardona CE; Guacheta M; Castillo DF; Reis LO
World J Urol; 2018 Dec; 36(12):1997-2008. PubMed ID: 29943218
[TBL] [Abstract][Full Text] [Related]
13. Comparison of outcomes between trimodal therapy and radical cystectomy in muscle-invasive bladder cancer: a propensity score matching analysis.
Kim YJ; Byun SJ; Ahn H; Kim CS; Hong BS; Yoo S; Lee JL; Kim YS
Oncotarget; 2017 Sep; 8(40):68996-69004. PubMed ID: 28978174
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Survival Outcomes With Trimodal Therapy as Primary Therapy for Non-organ-confined Bladder Cancer.
Guo Y; Jie X; Zhang A; Zhang W; Wang R; Zhang J; Mao S; Wu Y; Wang L; Zhang Z; Yan Y; Wang P; Yao X
Front Oncol; 2019; 9():1315. PubMed ID: 31867271
[No Abstract] [Full Text] [Related]
15. Trimodal therapy versus radical cystectomy for cT2N0M0 urothelial muscle-invasive bladder cancer: Single-center experience.
Fallatah M; Alkahtani AS; Alrumayyan M; Alotaibi MF; Alkhateeb S; Mokhtar AA; Altaweel W
Urol Ann; 2023; 15(4):406-411. PubMed ID: 38074180
[TBL] [Abstract][Full Text] [Related]
16. Long term cost comparisons of radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer.
Golla V; Shan Y; Farran EJ; Stewart CA; Vu K; Yu A; Khaki AR; Parikh DA; Swanson TA; Keegan KA; Kamat AM; Tyler DS; Freedland SJ; Williams SB
Urol Oncol; 2022 Jun; 40(6):273.e1-273.e9. PubMed ID: 35168881
[TBL] [Abstract][Full Text] [Related]
17. Efficiency of bladder-sparing strategies for bladder cancer: an umbrella review.
Li DX; Yu QX; Wu RC; Wang J; Feng DC; Deng S
Ther Adv Med Oncol; 2024; 16():17588359241249068. PubMed ID: 38736553
[TBL] [Abstract][Full Text] [Related]
18. Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis.
Qiu J; Zhang H; Xu D; Li L; Xu L; Jiang Y; Wen T; Lu S; Meng F; Feng L; Shu X
J Oncol; 2022; 2022():7306198. PubMed ID: 35607328
[TBL] [Abstract][Full Text] [Related]
19. Comparing Survival Outcomes and Costs Associated With Radical Cystectomy and Trimodal Therapy for Older Adults With Muscle-Invasive Bladder Cancer.
Williams SB; Shan Y; Jazzar U; Mehta HB; Baillargeon JG; Huo J; Senagore AJ; Orihuela E; Tyler DS; Swanson TA; Kamat AM
JAMA Surg; 2018 Oct; 153(10):881-889. PubMed ID: 29955780
[TBL] [Abstract][Full Text] [Related]
20. Predictors of trimodality therapy in patients with muscle-invasive bladder cancer and effect on survival.
Tang Y; Lin L; Xiao Y; Meng L; Yang Y; Li X
Clin Transl Oncol; 2024 Feb; 26(2):446-455. PubMed ID: 37389736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]